Barrington Research Maintains Outperform Rating for Concentrix: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Barrington Research has maintained its Outperform rating for Concentrix (NASDAQ:CNXC) but lowered its price target from $165.00 to $98.00. Concentrix shares are currently trading down 3.99% at $80.15 per share. A move to $98.00 would represent a 22.27% increase from the current share price.
June 29, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Barrington Research has maintained its Outperform rating for Concentrix but lowered its price target. This could potentially lead to a short-term decrease in the stock price.
The lowering of the price target by Barrington Research could lead to a decrease in the stock price in the short term as it may cause investors to reassess their valuation of the company. However, the maintained Outperform rating indicates that the analyst still believes the company will outperform the market, which could mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100